FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved Novo Nordisk's supplemental application for Wegovy (semaglutide).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

SUPPL AP for WEGOVY (SEMAGLUTIDE)